ポナチニブ薬の世界市場動向・分析2018-2025

【英語タイトル】Global Ponatinib Drugs Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

QYResearchが出版した調査資料(QYR8D08204)・商品コード:QYR8D08204
・発行会社(調査会社):QYResearch
・発行日:2018年11月13日
・ページ数:111
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国
・産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥539,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,078,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、ポナチニブ薬の世界市場について調査・分析し、種類別には、45mg、15mgに、用途別には、CML、ALLに区分してまとめました。調査対象企業は、ARIAD Pharmaceuticals等です。

・レポートの概要
・グローバル成長トレンド
・ポナチニブ薬の世界市場規模
・ポナチニブ薬の地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別ポナチニブ薬の価格動向
・ポナチニブ薬の種類別市場規模(45mg、15mg)
・ポナチニブ薬の用途別市場規模(CML、ALL)
・ポナチニブ薬の北米市場(アメリカ、カナダ、メキシコ)
・ポナチニブ薬のヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・ポナチニブ薬のアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・ポナチニブ薬の中南米市場(ブラジル等)
・ポナチニブ薬の中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(ARIAD Pharmaceuticals)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・ポナチニブ薬の市場規模予測
・ポナチニブ薬の種類別市場予測2018-2025(45mg、15mg)
・ポナチニブ薬の用途別市場予測2018-2025(CML、ALL)
・ポナチニブ薬の北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・ポナチニブ薬のヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・ポナチニブ薬のアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・ポナチニブ薬の中南米市場予測2018-2025(ブラジル等)
・ポナチニブ薬の中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL). In 2018, the global Ponatinib Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Ponatinib Drugs.

This study researches the market size of Ponatinib Drugs, presents the global Ponatinib Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Ponatinib Drugs in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Ponatinib Drugs for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
ARIAD Pharmaceuticals

Market Segment by Product Type
45mg
15mg

Market Segment by Application
CML
ALL

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Ponatinib Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Ponatinib Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Ponatinib Drugs are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Ponatinib Drugs Market Size Growth Rate by Type
1.3.2 45mg
1.3.3 15mg
1.4 Market Segment by Application
1.4.1 Global Ponatinib Drugs Market Share by Application (2018-2025)
1.4.2 CML
1.4.3 ALL
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Ponatinib Drugs Market Size
2.1.1 Global Ponatinib Drugs Revenue 2013-2025
2.1.2 Global Ponatinib Drugs Sales 2013-2025
2.2 Ponatinib Drugs Growth Rate by Regions
2.2.1 Global Ponatinib Drugs Sales by Regions 2013-2018
2.2.2 Global Ponatinib Drugs Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Ponatinib Drugs Sales by Manufacturers
3.1.1 Ponatinib Drugs Sales by Manufacturers 2013-2018
3.1.2 Ponatinib Drugs Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Ponatinib Drugs Revenue by Manufacturers (2013-2018)
3.2.2 Ponatinib Drugs Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Ponatinib Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Ponatinib Drugs Price by Manufacturers
3.4 Key Manufacturers Ponatinib Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Ponatinib Drugs Market
3.6 Key Manufacturers Ponatinib Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 45mg Sales and Revenue (2013-2018)
4.1.2 15mg Sales and Revenue (2013-2018)
4.2 Global Ponatinib Drugs Sales Market Share by Type
4.3 Global Ponatinib Drugs Revenue Market Share by Type
4.4 Ponatinib Drugs Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Ponatinib Drugs Sales by Application

6 North America
6.1 North America Ponatinib Drugs Breakdown Data by Company
6.2 North America Ponatinib Drugs Breakdown Data by Type
6.3 North America Ponatinib Drugs Breakdown Data by Application
6.4 North America Ponatinib Drugs Breakdown Data by Countries
6.4.1 North America Ponatinib Drugs Sales by Countries
6.4.2 North America Ponatinib Drugs Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Ponatinib Drugs Breakdown Data by Company
7.2 Europe Ponatinib Drugs Breakdown Data by Type
7.3 Europe Ponatinib Drugs Breakdown Data by Application
7.4 Europe Ponatinib Drugs Breakdown Data by Countries
7.4.1 Europe Ponatinib Drugs Sales by Countries
7.4.2 Europe Ponatinib Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Ponatinib Drugs Breakdown Data by Company
8.2 Asia Pacific Ponatinib Drugs Breakdown Data by Type
8.3 Asia Pacific Ponatinib Drugs Breakdown Data by Application
8.4 Asia Pacific Ponatinib Drugs Breakdown Data by Countries
8.4.1 Asia Pacific Ponatinib Drugs Sales by Countries
8.4.2 Asia Pacific Ponatinib Drugs Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Ponatinib Drugs Breakdown Data by Company
9.2 Central & South America Ponatinib Drugs Breakdown Data by Type
9.3 Central & South America Ponatinib Drugs Breakdown Data by Application
9.4 Central & South America Ponatinib Drugs Breakdown Data by Countries
9.4.1 Central & South America Ponatinib Drugs Sales by Countries
9.4.2 Central & South America Ponatinib Drugs Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Ponatinib Drugs Breakdown Data by Type
10.2 Middle East and Africa Ponatinib Drugs Breakdown Data by Application
10.3 Middle East and Africa Ponatinib Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Ponatinib Drugs Sales by Countries
10.3.2 Middle East and Africa Ponatinib Drugs Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 ARIAD Pharmaceuticals
11.1.1 ARIAD Pharmaceuticals Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Ponatinib Drugs
11.1.4 Ponatinib Drugs Product Introduction
11.1.5 ARIAD Pharmaceuticals Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Ponatinib Drugs Sales Channels
12.2.2 Ponatinib Drugs Distributors
12.3 Ponatinib Drugs Customers

13 Market Forecast
13.1 Global Ponatinib Drugs Sales and Revenue Forecast 2018-2025
13.2 Global Ponatinib Drugs Sales Forecast by Type
13.3 Global Ponatinib Drugs Sales Forecast by Application
13.4 Ponatinib Drugs Forecast by Regions
13.4.1 Global Ponatinib Drugs Sales Forecast by Regions 2018-2025
13.4.2 Global Ponatinib Drugs Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Ponatinib Drugs Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Ponatinib Drugs Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Ponatinib Drugs Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Ponatinib Drugs Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Ponatinib Drugs Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Ponatinib Drugs Product Picture
Table Ponatinib Drugs Key Market Segments
Table Major Manufacturers Ponatinib Drugs Covered in This Report
Table Global Ponatinib Drugs Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Ponatinib Drugs Sales Market Shar by Type 2013-2025
Figure 45mg Figures
Table Major Manufacturers of 45mg
Figure 15mg Figures
Table Major Manufacturers of 15mg
Table Global Ponatinib Drugs Market Share by Application 2018-2025 (K Units)
Figure CML Use Case
Figure ALL Use Case
Figure Ponatinib Drugs Report Years Considered
Figure Global Ponatinib Drugs Market Size 2013-2025 (Million US$)
Figure Global Ponatinib Drugs Sales 2013-2018 (K Units)
Table Global Ponatinib Drugs Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Ponatinib Drugs Sales by Regions 2013-2018 (K Units)
Table Global Ponatinib Drugs Sales Market Share by Regions 2013-2018
Figure Global Ponatinib Drugs Sales Market Share by Regions 2013-2018
Figure Global Ponatinib Drugs Sales Market Share by Regions in 2018
Table Global Ponatinib Drugs Revenue by Regions 2013-2018 (Million US$)
Table Global Ponatinib Drugs Revenue Market Share by Regions 2013-2018
Figure Global Ponatinib Drugs Revenue Market Share by Regions 2013-2018
Figure Global Ponatinib Drugs Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Ponatinib Drugs Sales by Manufacturers (2013-2018) (K Units)
Table Global Ponatinib Drugs Sales Share by Manufacturers (2013-2018)
Figure Global Ponatinib Drugs Sales Share by Manufacturers in 2018
Table Ponatinib Drugs Revenue by Manufacturers (2013-2018) (Million USD)
Table Ponatinib Drugs Revenue Share by Manufacturers (2013-2018)
Figure Ponatinib Drugs Value Share by Manufacturers in 2018
Table Global Ponatinib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Ponatinib Drugs Price (2013-2018) (USD/Unit)
Table Key Manufacturers Ponatinib Drugs Plants/Factories Distribution
Table Key Manufacturers Ponatinib Drugs Area Served
Table Date of Key Manufacturers Enter into Ponatinib Drugs Market
Table Key Manufacturers Ponatinib Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global 45mg Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 15mg Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Ponatinib Drugs Sales by Type (2013-2018) (K Units)
Table Global Ponatinib Drugs Sales Share by Type (2013-2018)
Figure Global Ponatinib Drugs Sales Market Share by Type (2013-2018)
Figure Global Ponatinib Drugs Sales Market Share by Type in 2017
Table Global Ponatinib Drugs Revenue by Type (2013-2018) (Million US$)
Table Global Ponatinib Drugs Revenue Share by Type (2013-2018)
Figure Global Ponatinib Drugs Revenue Market Share by Type (2013-2018)
Figure Global Ponatinib Drugs Revenue Market Share by Type in 2017
Table Ponatinib Drugs Price by Type 2013-2018 (USD/Unit)
Table Global Ponatinib Drugs Sales by Application (2013-2018) (K Units)
Table Global Ponatinib Drugs Sales Share by Application (2013-2018)
Figure Global Sales Ponatinib Drugs Market Share by Application (2013-2018)
Figure Global Sales Ponatinib Drugs Market Share by Application in 2017
Figure North America Ponatinib Drugs Sales Growth Rate 2013-2018 (K Units)
Figure North America Ponatinib Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table North America Ponatinib Drugs Sales by Company (2013-2018) (K Units)
Table North America Ponatinib Drugs Sales Market Share by Company (2013-2018)
Figure North America Ponatinib Drugs Sales Market Share by Company in 2018
Table North America Ponatinib Drugs Sales by Type (2013-2018) (K Units)
Table North America Ponatinib Drugs Sales Market Share by Type (2013-2018)
Figure North America Ponatinib Drugs Market Share by Type in 2018
Table North America Ponatinib Drugs Sales by Application (2013-2018) (K Units)
Table North America Ponatinib Drugs Sales Market Share by Application (2013-2018)
Figure North America Ponatinib Drugs Market Share by Application in 2018
Table North America Ponatinib Drugs Sales by Countries (2013-2018) (K Units)
Table North America Ponatinib Drugs Sales Market Share by Countries (2013-2018)
Figure 2017 North America Ponatinib Drugs Sales Market Share by Countries
Table North America Ponatinib Drugs Revenue by Countries (2013-2018) (Million US$)
Table North America Ponatinib Drugs Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Ponatinib Drugs Revenue Market Share by Countries
Figure United States Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Canada Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Europe Ponatinib Drugs Sales Growth Rate 2013-2018 (K Units)
Figure Europe Ponatinib Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Ponatinib Drugs Sales by Company (2013-2018) (K Units)
Table Europe Ponatinib Drugs Sales Market Share by Company (2013-2018)
Figure Europe Ponatinib Drugs Sales Market Share by Company in 2018
Table Europe Ponatinib Drugs Sales by Type (2013-2018) (K Units)
Table Europe Ponatinib Drugs Sales Market Share by Type (2013-2018)
Figure 2017 Europe Ponatinib Drugs Market Share by Type
Table Europe Ponatinib Drugs Sales by Application (2013-2018) (K Units)
Table Europe Ponatinib Drugs Sales Market Share by Application (2013-2018)
Figure 2017 Europe Ponatinib Drugs Market Share by Application
Table Europe Ponatinib Drugs Sales by Countries (2013-2018) (K Units)
Table Europe Ponatinib Drugs Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Ponatinib Drugs Sales Market Share by Countries
Table Europe Ponatinib Drugs Revenue by Countries (2013-2018) (Million US$)
Table Europe Ponatinib Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Ponatinib Drugs Revenue Market Share by Countries in 2018
Figure Germany Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure France Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure UK Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Italy Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Russia Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Ponatinib Drugs Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Ponatinib Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Ponatinib Drugs Sales by Company (2013-2018) (K Units)
Table Asia Pacific Ponatinib Drugs Sales Market Share by Company (2013-2018)
Figure Asia Pacific Ponatinib Drugs Sales Market Share by Company in 2018
Table Asia Pacific Ponatinib Drugs Sales by Type (2013-2018) (K Units)
Table Asia Pacific Ponatinib Drugs Sales Market Share by Type (2013-2018)
Figure Asia Pacific Ponatinib Drugs Market Share by Type in 2018
Table Asia Pacific Ponatinib Drugs Sales by Application (2013-2018) (K Units)
Table Asia Pacific Ponatinib Drugs Sales Market Share by Application (2013-2018)
Figure Asia Pacific Ponatinib Drugs Market Share by Application in 2018
Table Asia Pacific Ponatinib Drugs Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Ponatinib Drugs Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Ponatinib Drugs Sales Market Share by Countries
Table Asia Pacific Ponatinib Drugs Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Ponatinib Drugs Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Ponatinib Drugs Revenue Market Share by Countries
Figure China Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure China Ponatinib Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Japan Ponatinib Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Korea Ponatinib Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure India Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure India Ponatinib Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Australia Ponatinib Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Ponatinib Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Ponatinib Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Ponatinib Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Ponatinib Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Ponatinib Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Central & South America Ponatinib Drugs Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Ponatinib Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Ponatinib Drugs Sales by Company (2013-2018) (K Units)
Table Central & South America Ponatinib Drugs Sales Market Share by Company (2013-2018)
Figure Central & South America Ponatinib Drugs Sales Market Share by Company in 2018
Table Central & South America Ponatinib Drugs Sales by Type (2013-2018) (K Units)
Table Central & South America Ponatinib Drugs Sales Market Share by Type (2013-2018)
Figure Central & South America Ponatinib Drugs Market Share by Type in 2018
Table Central & South America Ponatinib Drugs Sales by Application (2013-2018) (K Units)
Table Central & South America Ponatinib Drugs Sales Market Share by Application (2013-2018)
Figure Central & South America Ponatinib Drugs Market Share by Application in 2018
Table Central & South America Ponatinib Drugs Sales by Countries (2013-2018) (K Units)
Table Central & South America Ponatinib Drugs Sales Market Share by Countries (2013-2018)
Figure Central & South America Ponatinib Drugs Sales Market Share by Countries in 2018
Table Central & South America Ponatinib Drugs Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Ponatinib Drugs Revenue Market Share by Countries (2013-2018)
Figure Central & South America Ponatinib Drugs Revenue Market Share by Countries in 2018
Figure Brazil Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Ponatinib Drugs Revenue Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Ponatinib Drugs Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Ponatinib Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Ponatinib Drugs Sales by Type (2013-2018) (K Units)
Table Middle East and Africa Ponatinib Drugs Sales Market Share by Type (2013-2018)
Figure 2017 Middle East and Africa Ponatinib Drugs Market Share by Type
Table Middle East and Africa Ponatinib Drugs Sales by Application (2013-2018) (K Units)
Table Middle East and Africa Ponatinib Drugs Sales Market Share by Application (2013-2018)
Figure 2017 Middle East and Africa Ponatinib Drugs Market Share by Application
Table Middle East and Africa Ponatinib Drugs Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Ponatinib Drugs Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Ponatinib Drugs Sales Market Share by Countries
Table Middle East and Africa Ponatinib Drugs Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Ponatinib Drugs Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Ponatinib Drugs Revenue Market Share by Countries
Figure GCC Countries Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Ponatinib Drugs Revenue Growth Rate (2013-2018) (K Units)
Figure Egypt Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Ponatinib Drugs Revenue Growth Rate (2013-2018) (K Units)
Figure South Africa Ponatinib Drugs Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Ponatinib Drugs Revenue Growth Rate (2013-2018) (K Units)
Table ARIAD Pharmaceuticals Company Details
Table ARIAD Pharmaceuticals Description and Business Overview
Table ARIAD Pharmaceuticals Ponatinib Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table ARIAD Pharmaceuticals Ponatinib Drugs Sales Growth Rate (2013-2018)
Table ARIAD Pharmaceuticals Ponatinib Drugs Sales Market Share in Global Market
Table ARIAD Pharmaceuticals Recent Development
Figure Ponatinib Drugs Value Chain
Table Ponatinib Drugs Distributors List
Table Ponatinib Drugs Customers List
Table Global Ponatinib Drugs Sales Forecast 2018-2025 (K Units) & (Million US$)
Figure Global Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Figure Global Ponatinib Drugs Revenue Forecast 2018-2025 (Million US$)
Table Global Ponatinib Drugs Sales Forecast by Type 2018-2025 (K Units)
Figure Global Ponatinib Drugs Sales Forecast by Type 2018-2025 (K Units)
Figure Global Ponatinib Drugs Sales Market Share Forecast by Type 2018-2025
Table Global Ponatinib Drugs Sales Forecast by Application 2018-2025 (K Units)
Figure Global Ponatinib Drugs Sales Forecast by Application 2018-2025 (K Units)
Figure Global Ponatinib Drugs Sales Market Share Forecast by Application 2018-2025
Table Global Ponatinib Drugs Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Ponatinib Drugs Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Ponatinib Drugs Sales Market Share Forecast by Regions 2018-2025
Table Global Ponatinib Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Ponatinib Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Ponatinib Drugs Revenue Market Share Forecast by Regions 2018-2025
Table North America Ponatinib Drugs Sales Forecast by Countries 2018-2025 (K Units)
Table North America Ponatinib Drugs Sales Market Share Forecast by Countries 2018-2025
Table North America Ponatinib Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
Table North America Ponatinib Drugs Revenue Market Share Forecast by Countries 2018-2025
Figure United States Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Figure Canada Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Figure MexicoPonatinib Drugs Sales Forecast 2018-2025 (K Units)
Table Europe Ponatinib Drugs Sales Forecast by Countries 2018-2025 (K Units)
Table Europe Ponatinib Drugs Sales Market Share Forecast by Countries 2018-2025
Table Europe Ponatinib Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
Table Europe Ponatinib Drugs Revenue Market Share Forecast by Countries 2018-2025
Figure Germany Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Figure France Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Figure UK Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Figure Italy Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Figure Russia Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Table Asia Pacific Ponatinib Drugs Sales Forecast by Countries 2018-2025 (K Units)
Table Asia Pacific Ponatinib Drugs Sales Market Share Forecast by Countries 2018-2025
Table Asia Pacific Ponatinib Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
Table Asia Pacific Ponatinib Drugs Revenue Market Share Forecast by Countries 2018-2025
Figure China Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Figure Japan Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Figure Korea Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Figure India Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Figure Australia Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Figure Indonesia Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Figure Thailand Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Figure Malaysia Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Figure Philippines Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Figure Vietnam Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Table Central & South America Ponatinib Drugs Sales Forecast by Countries 2018-2025 (K Units)
Table Central & South America Ponatinib Drugs Sales Market Share Forecast by Countries 2018-2025
Table Central & South America Ponatinib Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
Table Central & South America Ponatinib Drugs Revenue Market Share Forecast by Countries 2018-2025
Figure Brazil Ponatinib Drugs Sales Forecast 2018-2025 (K Units)
Table Middle East and Africa Ponatinib Drugs Sales Forecast by Regions 2018-2025 (K Units)
Table Middle East and Africa Ponatinib Drugs Sales Market Share Forecast by Regions 2018-2025
Table Middle East and Africa Ponatinib Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
Table Middle East and Africa Ponatinib Drugs Revenue Market Share Forecast by Regions 2018-2025
Figure GCC Countries Ponatinib Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Ponatinib Drugs Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Ponatinib Drugs Sales Growth Rate (2016-2025) (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

ARIAD Pharmaceuticals

★調査レポート[ポナチニブ薬の世界市場動向・分析2018-2025] (コード:QYR8D08204)販売に関する免責事項を必ずご確認ください。
★調査レポート[ポナチニブ薬の世界市場動向・分析2018-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆